India, Jan. 27 -- The alleged Rs 157 crore international counterfeit Ozempic scam, which sent shockwaves through the global pharmaceutical community last year, continues to escalate.

What began as a high-stakes supply agreement between an Indian firm and US-based Assure Global LLC has spiralled into a criminal investigation involving forged court documents, transnational conspiracy, and the distribution of "spurious" drugs seized by US authorities.

At the centre of the storm is Vicky Ramancha, CEO of an Indian pharma entity and R&R Global Procurement Corp. He stands accused of orchestrating a sophisticated fraud, allegedly leveraging fake Government credentials and forged notarised papers from the Patiala House Courts to build a facade ...